Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
106
NCT03191864
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 22, 2017
Completion: Oct 23, 2019